Pages that link to "Q43503837"
Jump to navigation
Jump to search
The following pages link to Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex (Q43503837):
Displaying 27 items.
- Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 (Q24293326) (← links)
- The female athlete triad (Q24605890) (← links)
- Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation (Q28315419) (← links)
- Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer (Q28344327) (← links)
- Estroprogestinic pill normalizes IGF-I levels in acromegalic women. (Q34211296) (← links)
- Antepartal insulin-like growth factor concentrations indicating differences in the metabolic adaptive capacity of dairy cows (Q34258529) (← links)
- Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study (Q34627034) (← links)
- Serum levels of insulin-like growth factor I and its binding proteins in health and disease (Q35197911) (← links)
- Indirect evidence of hormone abuse. Proof of doping? (Q35667586) (← links)
- Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa (Q35832419) (← links)
- Oral contraceptive use and fracture risk around the menopausal transition (Q36515593) (← links)
- Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. (Q37379541) (← links)
- Bone Health in Athletes (Q39002200) (← links)
- Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters (Q40521614) (← links)
- Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C. (Q42150842) (← links)
- Effect of conjugated estrogens on free IGF-I? (Q43746476) (← links)
- Gender and age influence the relationship between serum GH and IGF-I in patients with acromegaly (Q44051792) (← links)
- Serum Sex Hormones, IGF-1, and IGFBP3 Exert a Sexually Dimorphic Effect on Lean Body Mass in Aging (Q44514751) (← links)
- Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens (Q44555045) (← links)
- Is testosterone and estrogen priming prior to clonidine useful in the evaluation of the growth hormone status of short peripubertal children? (Q46550835) (← links)
- Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender (Q46685774) (← links)
- Neurotrophic and Neuroregenerative Effects of GH/IGF1. (Q47152037) (← links)
- Hormone replacement therapy and cancer risk: A systematic analysis from a network of case‐control studies (Q47963206) (← links)
- Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function (Q48569734) (← links)
- Effects of Toremifene, a Selective Estrogen Receptor Modulator, on Spontaneous and Stimulated GH Secretion, IGF-I, and IGF-Binding Proteins in Healthy Elderly Subjects (Q51248114) (← links)
- The effects of oestrogens on linear bone growth (Q57420685) (← links)
- Transdermal Estrogen in Women With Anorexia Nervosa: An Exploratory Pilot Study (Q92761123) (← links)